Search Results 101-110 of 16354 for isotretinoin

  1. Rosiglitazone (oral route) - Mayo Clinic

    Rosiglitazone is used to treat a type of diabetes mellitus called type 2 diabetes. It may be used alone or with other medicines such as metformin or ...

  2. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  3. Congenital heart disease in adults - Diagnosis and treatment - Mayo Clinic

    Ami TR. Allscripts EPSi. Mayo Clinic. Feb. 23, 2024. Isotretinoin. Facts & Comparisons eAnswers. https://www.wolterskluwercdi.com/facts-comparisons-online.

  4. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

    The objective of Study M15-991 is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to ...

  5. A Study to Evaluate Preoperative Oral Microbiota-Based Investigational New Drug to Target Immune Response in Patients with Operable Stage I-III Breast Cancer - Mayo Clinic

    The primary purposes of this trial are to determine the safety and tolerability of RBX7455 given for at least 2 weeks and not more than 4 weeks prior to surgery ...

  6. Phase I Trial of Sargramostim and Nivolumab for Metastatic Melanoma to the Lung - Mayo Clinic

    About this study. This phase I trial is looking to see if sargramostim given with a nebulizer, in combination with standard immune checkpoint inhibitor ...

  7. Publications - Mark R. Pittelkow, M.D. - Mayo Clinic

    Isotretinoin Exposure and Risk of Inflammatory Bowel Disease. JAMA Dermatol. 2014 Dec 1; 150(12):1322-6. View PubMed; Sio TT, Pittelkow MR, Nagle MA, Martenson ...

  8. Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery - Mayo Clinic

    About this study. This phase II trial studies how well sapanisertib works in treating patients with pancreatic neuroendocrine tumor that has spread to other ...

  9. A Study to Evaluate Intravenous Erenumab in Patients with Status Migrainosus - Mayo Clinic

    The purpose of this study is to investigate the use of erenumab 140mg IV in patients with status migrainosus. The specific aims of the study are to evaluate ...

  10. Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...